Limited improvement of incorporating primary circulating prostate cells with the CAPRA score to predict biochemical failure-free outcome of radical prostatectomy for prostate cancer
详细信息 查看全文
- 作者：Nigel P. Murray ; M.R.C.P.a ; npmurrmc2@gmail.com" class="auth_mail" title="E-mail the corresponding author ; nigelpetermurray@gmail.com" class="auth_mail" title="E-mail the corresponding author ; Socrates Aedo ; M.D.b ; Cynthia Fuentealba ; M.D.c ; Omar Jacob ; M.D.c ; Eduardo Reyes ; M.D.d ; Camilo Novoa ; M.B. ; B.C.H.e ; Sebastian Orellanaf ; Nelson Orellana ; M.D.g
- 关键词：CAPRA score ; Prostate cancer ; Circulating prostate cells ; Biochemical failure
- 刊名：Urologic Oncology: Seminars and Original Investigations
- 出版年：2016
- 出版时间：October 2016
- 年：2016
- 卷：34
- 期：10
- 页码：430.e17-430.e25
- 全文大小：439 K
文摘
- •
In the discussion section, we (in blue) discuss the use of secondary circulating prostate cells as a prognostic biomarker, their significance, and possible role as a sign of minimal residual disease.
- •
Presence of primary CPCs has limited prognostic role.
- •
Frequently detected in men with prostate cancer.
- •
may have role in cancer detection.